by RDBiomed | Jun 17, 2026 | Latest Pepsin Research
Pepsin and oral thrush together may reduce how well metals used in braces are protected in the mouth, according to a new lab study published in Scientific Reports. The paper, Pepsin-driven corrosion of orthodontic titanium alloys in candidiasis-simulated saliva:...
by rdbiomed | Dec 17, 2025 | Latest Pepsin Research, Reflux Tips & News
New analysis suggests an association between long-term exposure to air pollution and higher rates of gastro-oesophageal reflux disease (GERD). It appears the air we breathe matters: exposure to traffic fumes and fine particles is linked with higher risk of reflux...
by rdbiomed | Apr 19, 2024 | Latest Pepsin Research, LPR
Medication approved for the treatment of HIV has caught the attention of researchers for potentially helping with the management of laryngopharyngeal reflux (LPR). LPR occurs when stomach acid and digestive enzymes, including pepsin, travel up the oesophagus and into...
by rdbiomed | May 3, 2023 | Latest Pepsin Research
Researchers have found a link between a type of reflux and the development of cancerous cells in the hypopharynx (that’s the area behind the tongue and above the oesophagus). The study examines how the enzyme pepsin can contribute to laryngeal inflammation...
by rdbiomed | Apr 21, 2023 | Company Updates, Latest Pepsin Research
Reflux disease – often called acid reflux – is a condition where stomach contents flow back into the oesophagus, causing heartburn, regurgitation, and other related symptoms. We know that certain foods and beverages can trigger reflux, but there is still much to...
by rdbiomed | Nov 24, 2022 | Latest Pepsin Research, reflux treatments
At the World Cancer Congress (WCC) in Switzerland, researchers presented evidence linking exposure to proton pump inhibitors (PPIs) with an increased risk for certain cancers. The Congress, which took place in Geneva on 18 to 20 October 2022, invited experts to help...
Recent Comments